Infosheets

Results of previous calls
Programmes EDF

Published on | 1 year ago

Last updated on | 6 months ago

Author Do you have an additional question? Or spotted a mistake? Don't hesitate to contact me!
Image of Mark Antonissen
Mark Antonissen

mark.antonissen@vlaio.be

Result of the EDF 2023 Calls for Proposals

Following the third calls for proposals under the European Defence Fund (EDF), 54 collaborative defence research and development projects with a total EU support of almost €1,031million are selected for funding.

Result of the EDF 2022 Calls for Proposals

Following the second calls for proposals under the European Defence Fund (EDF), 41 collaborative defence research and development projects with a total EU support of almost €832 Million are selected for funding.

myOverview - sign up for personalised information

We offer news and event updates, covering all domains and topics of Horizon Europe, Digital Europe & EDF (and occasionally, for ongoing projects, Horizon 2020).

Stay informed about what matters to you. By signing up, you can opt in for e-mail notifications and get access to a personalised dashboard that groups all news updates and event announcements in your domain(s).

Only for stakeholders located in Flanders

Testimonial

image of BEAT-AF - Ground-Breaking Electroporation-based intervention for Atrial Fibrillation treatment

BEAT-AF - Ground-Breaking Electroporation-based intervention for Atrial Fibrillation treatment

The Horizon2020 project BEAT-AF brings together 9 European renowned clinical centres in France, Belgium, Czechia, Germany and Austria. Together, the consortium strives to revolutionize Atrial Fibrillation (AF) treatment through catheter ablation and contribute to decrease the huge burden of AF in Europe. The BEAT-AF project kicked off in 2021 and will run until 2026. The department of electrophysiology of the AZ Sint-Jan Hospital in Bruges is partner in the project and has so far contributed to the pre-clinical development, the first in man studies and first registries of the revolutionary AF treatment put forward by the consortium. The first pilot studies show that the treatment is safe, effective and efficient.